Gammagard liquid 10% vial 200ML
Ended Awarded
- Contract number
- SPE2DB25FDL13
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,620
Award facts
- Contract value 100% obligated
- $35,620.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $35.6K by the Defense Logistics Agency (DLA) for Gammagard Liquid 10% in 200mL vials. The contract is firm fixed-price with no set-aside designation and carries an ultimate completion date of September 9, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500M and extending through November 2026, which authorizes the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Gammagard Liquid 10% is an intravenous immunoglobulin (IVIG) therapy used to treat various immunodeficiency conditions and autoimmune disorders within the Department of Defense healthcare system. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent success in securing delivery orders for specialty medications, biologics, and other pharmaceutical products essential to military medical operations. The company's established position as a woman-owned small business and its robust portfolio of federal contracts underscore its capability to reliably deliver specialized pharmaceutical products to defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FDL13?
SPE2DB25FDL13 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FDL13 worth?
The government has obligated $35,620 on SPE2DB25FDL13.
Is contract SPE2DB25FDL13 an order under another contract?
Yes. SPE2DB25FDL13 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL13 competed?
The extent of competition for SPE2DB25FDL13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award